Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kith Pradhan

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
Neuron|May 1, 2012
De novo gene disruptions in children on the autistic spectrumIvan Iossifov, Michael Ronemus, Dan Levy, et al.
Cancer Discovery|October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal ExpansionDivij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Cancer Research|July 8, 2017
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin ActivationTushar D Bhagat, Si Chen, Matthias Bartenstein, et al.
Nature Medicine|March 8, 2022
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disasterSakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, et al.
Research Square|March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analysesMarina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Stem Cell Investigation|October 11, 2021
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world settingAstha Thakkar, Zhu Cui, Stephen Zachary Peeke, et al.
Nature Cancer|September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analysesCourtney D DiNardo, Divij Verma, Natalia Baran, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Leukemia|February 17, 2026
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemiaSamarpana Chakraborty, Claudia Morganti, Kimberly Zaldana, et al.
Neuron|May 1, 2012
De novo gene disruptions in children on the autistic spectrumIvan Iossifov, Michael Ronemus, Dan Levy, et al.
Cancer Discovery|October 1, 2025
Elevated Clonal Hematopoiesis in 9/11 First Responders Has Distinct Age-related Patterns and Relies on IL1RAP for Clonal ExpansionDivij Verma, Rachel Zeig-Owens, David G Goldfarb, et al.
Cancer Research|July 8, 2017
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin ActivationTushar D Bhagat, Si Chen, Matthias Bartenstein, et al.
Nature Medicine|March 8, 2022
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disasterSakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, et al.
Research Square|March 3, 2023
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analysesMarina Konopleva, Courtney DiNardo, Tushar Bhagat, et al.
Stem Cell Investigation|October 11, 2021
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world settingAstha Thakkar, Zhu Cui, Stephen Zachary Peeke, et al.
Nature Cancer|September 19, 2024
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analysesCourtney D DiNardo, Divij Verma, Natalia Baran, et al.
Pageof 9